Herzog & de Meuron has unveiled plans for the modernization of the Roche pharmaceutical company’s Basel headquarters. With the first tower already under construction, the overall vision is to consolidate and update all existing facilities, including a historic Otto R. Salvisberg-designed office building, as well as construct a new, four-tower research center and 205-meter tall office tower by 2022.
“The planned consolidation of the existing industrial site will eliminate the need to build over green zones”, emphasizes Jürg Erismann, Head of the Basel/Kaiseraugst Site. “Instead, Roche will be making more efficient use of those parts of the site that have already been developed but cannot be expanded.”
In this extended interview between Bernard Tschumi and The Architectural Review’s Paul Finch, the pre-eminent Swiss-born architect discusses his education, writing, design and wider critical position. Speaking candidly, Tschumi explains how a visit to Chicago when he was seventeen years old sparked a life-long passion for architectural design - something that had been somewhat repressed due to his father who was, at that time, one of the world’s most highly respected architects. His friendship with British architect and theorist Cedric Price led to the start of a career that saw his proposals for Paris’s Parc de la Villette foreshadow the age of Deconstructivism. Ending with his take on the future of the profession, Tschumi also offers advice to students and young practices looking to make their mark.